Potassium Chloride Extended-release
Generic Name: potassium chloride extended-release
Brand Names:
Potassium Chloride Extended-release
Extended-release oral dosage form containing microencapsulated potassium chloride for the treatment and prevention of hypokalemia.
Overview
Extended-release oral dosage form containing microencapsulated potassium chloride for the treatment and prevention of hypokalemia.
Uses
Treatment of hypokalemia with or without metabolic alkalosis, digitalis intoxication, hypokalemic familial periodic paralysis. Prevention of hypokalemia in at-risk patients.
Dosage
Typical prevention dose is 20 mEq daily. Treatment doses range 40-100 mEq daily in divided doses. Take with meals and water. Do not exceed 20 mEq per single dose.
Side Effects
Most common: nausea, vomiting, flatulence, abdominal pain or discomfort, diarrhea. Severe: hyperkalemia, GI obstruction, bleeding, ulceration, perforation.
Interactions
Potassium-sparing diuretics, ACE inhibitors, and NSAIDs may increase risk of hyperkalemia.
Warnings
Risk of hyperkalemia in impaired renal function. GI lesions possible with solid oral dosage forms. Contraindicated with potassium-sparing diuretics and in patients with hyperkalemia or structural GI delays.
Pregnancy
Unlikely that potassium supplementation not causing hyperkalemia would adversely affect fetus. Normal milk potassium content approximately 13 mEq/liter.
Storage
Store at 20-25 degrees C (68-77 degrees F). Excursions permitted to 15-30 degrees C.
Frequently Asked Questions
What is Potassium Chloride Extended-release used for?▼
Treatment of hypokalemia with or without metabolic alkalosis, digitalis intoxication, hypokalemic familial periodic paralysis. Prevention of hypokalemia in at-risk patients.
What are the side effects of Potassium Chloride Extended-release?▼
Most common: nausea, vomiting, flatulence, abdominal pain or discomfort, diarrhea. Severe: hyperkalemia, GI obstruction, bleeding, ulceration, perforation.
Can I take Potassium Chloride Extended-release during pregnancy?▼
Unlikely that potassium supplementation not causing hyperkalemia would adversely affect fetus. Normal milk potassium content approximately 13 mEq/liter.
What are the important warnings for Potassium Chloride Extended-release?▼
Risk of hyperkalemia in impaired renal function. GI lesions possible with solid oral dosage forms. Contraindicated with potassium-sparing diuretics and in patients with hyperkalemia or structural GI delays.
Related Medications
Venlafaxine Hcl
venlafaxine hcl
11. Description Venlafaxine hydrochloride extended-release capsules USP are an extended-release capsule for once-a-day oral administration that contains venlafaxine hydrochloride, a SNRI. Venlafaxine is designated Cyclohexanol,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride or (±)-1-[α-[(dimethylamino)methyl]-p-methoxybenzyl]cyclohexanol hydrochloride and has the empirical formula of C 17H 27NO 2 HCl. Its molecular weight is 313.9.
Griseofulvin
griseofulvin
Tubulin Inhibiting Agent [EPC]
DESCRIPTION Ultramicrosize griseofulvin tablets, USP contain ultramicrosize crystals of griseofulvin, an antibiotic derived from a species of Penicillium . Griseofulvin crystals are partly dissolved in polyethylene glycol 8000 and partly dispersed throughout the tablet matrix. The chemical name of griseofulvin, USP is 7-Chloro-2’,4,6-trimethoxy-6’β-methylspiro[benzofuran-2( 3H ),1’-[2]cyclohexene]-3,4’-dione.
Aluminium Bromatum
aluminium bromatum
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.